Anti-wrinkle drugs to carry FDA's strongest warning

05/1/2009 | NYTimes.com

Botox, Dysport and other anti-wrinkle treatments must come with a black-box warning indicating that the drugs can spread from the injection site and trigger side effects such as difficulty swallowing and breathing, the FDA said. The agency added that adverse reactions were seen mainly in patients who were given excessive doses of the drugs for off-label use.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park